Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

m-Aminophenol in hair dye can cause skin cell toxicity and stress responses.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Dermoscopic and histopathological features combined can help diagnose Pityriasis versicolor.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

Cells that move well may improve hair loss treatments by entering hair follicles.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

Targeted cancer therapies often cause serious skin problems that need careful management.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

No single biomarker is reliable enough for diagnosing and assessing SLE.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.